Base de dados : MEDLINE
Pesquisa : N03.540.514 [Categoria DeCS]
Referências encontradas : 7580 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 758 ir para página                         

  1 / 7580 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29267410
[Au] Autor:Joly L
[Ad] Endereço:Université de Bordeaux, COMPTRASEC - UMR CNRS 5114.
[Ti] Título:[Employment of People with Mental Disorders in Terms of the Policies Developed by the European and International Institutions].
[Ti] Título:L'emploi des personnes atteintes de troubles psychiques à l'aune des politiques développées par les institutions européennes et internationales..
[So] Source:Sante Ment Que;42(2):17-30, 2017.
[Is] ISSN:0383-6320
[Cp] País de publicação:Canada
[La] Idioma:fre
[Ab] Resumo:Objectives The aim of this article is to present an overview of the reflections led by various European and international organizations on the employment of people with mental disorders.Methods This study is based on data from websites of international organizations and interviews taken place with a disability specialist at the International Labour Organisation (ILO) and members of the European Commission.Results Unlike the French law of 11 February 2005 which refers expressly to psychic disability, this notion is not explicitly dedicated by various European and international legal rules. However, these standards like the United Nations Convention on the Rights of Persons with Disabilities have adopted the contemporary model which presents disability as the result of an interaction between person and environment. Thus they acknowledge that disabled people include people suffering from mental disorders because in the person's environment, a psychiatric impairment could lead to limitations of activities or restrictions of social participation that constitute a situation of disability of psychiatric origin. Therefore, the legal mechanisms often do not provide appropriate answers to the characteristics of psychiatric disability.Besides, negative attitudes, stereotypes and discrimination towards people with a psychiatric disability are still observed in the workplace, in spite of intensified anti-discrimination legislation.This study inventories the different proposals to remedy to substantial barriers to the employment of people with a psychiatric condition. In the European Union's strategy for increasing the employment of these persons, particular consideration is given to put forward a series of key recommendations to improve practices of reasonable accommodation in the workplace. Nonetheless, it must be emphasized that it is necessary to conceive adequate measures in order to take into account the changeability and the unpredictability of mental disorders. Indeed, situations of psychiatric disability require flexibility and reactivity more than any other situation of disability. The discrimination experienced by people with a psychiatric disability is likely to continue as long as specific responses are not implemented. In this perspective, ILO highlights a number of best practices addressing the challenges of psychiatric disabled people's employment. That is why a disability network was created to share knowledge. The great added value of this network is the opportunity to share best practices between companies, best practices between countries in order to increase the ability to include people with mental disorders. Focus is put on strategies to combat discrimination in employment, by raising awareness, exploring measures and good practices to improve mental health in the workplace.Conclusion Finally, this study shows similar challenges in the prevention of the mental health and the issue of the psychiatric handicap, including to remedy to the insufficient attention paid to provide reasonable accommodation to persons with mental disorders.
[Mh] Termos MeSH primário: Emprego/legislação & jurisprudência
Transtornos Mentais
[Mh] Termos MeSH secundário: Europa (Continente)
Seres Humanos
Agências Internacionais
Pessoas com Deficiência Mental
Políticas
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171222
[St] Status:MEDLINE


  2 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29397523
[Au] Autor:Robson AG; Nilsson J; Li S; Jalali S; Fulton AB; Tormene AP; Holder GE; Brodie SE
[Ad] Endereço:Department of Electrophysiology, Moorfields Eye Hospital, 162 City Road, London, UK. anthony.robson@moorfields.nhs.uk.
[Ti] Título:ISCEV guide to visual electrodiagnostic procedures.
[So] Source:Doc Ophthalmol;136(1):1-26, 2018 02.
[Is] ISSN:1573-2622
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:Clinical electrophysiological testing of the visual system incorporates a range of noninvasive tests and provides an objective indication of function relating to different locations and cell types within the visual system. This document developed by the International Society for Clinical Electrophysiology of Vision provides an introduction to standard visual electrodiagnostic procedures in widespread use including the full-field electroretinogram (ERG), the pattern electroretinogram (pattern ERG or PERG), the multifocal electroretinogram (multifocal ERG or mfERG), the electrooculogram (EOG) and the cortical-derived visual evoked potential (VEP). The guideline outlines the basic principles of testing. Common clinical presentations and symptoms are described with illustrative examples and suggested investigation strategies.
[Mh] Termos MeSH primário: Eletrodiagnóstico/normas
Eletroculografia
Eletrofisiologia/organização & administração
Eletrorretinografia/métodos
Potenciais Evocados Visuais
Guias de Prática Clínica como Assunto
[Mh] Termos MeSH secundário: Seres Humanos
Agências Internacionais
Doenças do Nervo Óptico/diagnóstico
Doenças Retinianas/diagnóstico
Sociedades Médicas
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180205
[St] Status:MEDLINE
[do] DOI:10.1007/s10633-017-9621-y


  3 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28971825
[Au] Autor:Abdel-Wahab M; Lahoupe B; Polo A; Zubizarreta E; Adnan RR; Johnston P; Juric A; Haffar FE; Andre M; Meghzifene A
[Ad] Endereço:Division of Human Health, International Atomic Energy Agency, Vienna, Austria. Electronic address: wahabmay@hotmail.com.
[Ti] Título:Assessment of cancer control capacity and readiness: the role of the International Atomic Energy Agency.
[So] Source:Lancet Oncol;18(10):e587-e594, 2017 Oct.
[Is] ISSN:1474-5488
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:During the past six decades, the International Atomic Energy Agency (IAEA) has helped to address the growing cancer burden, by delivering substantial cancer-related assistance to low-income and middle-income member states. IAEA assistance has primarily been facilitated through sustainable radiotherapy and nuclear medicine programmes to establish safe and effective diagnostic imaging, nuclear medicine, and radiotherapy capacity to safely treat patients with cancer. Planning of a National Cancer Control Programme starts with a needs assessment of all aspects of cancer control in the country to ensure evidence-based strategies are adapted to the country's specific needs. The IAEA offers its member states a tool, known as an integrated mission of Programme of Action for Cancer Therapy Review, to assess the status of national capacities for implementation and delivery of cancer control plans and activities and the readiness to develop and implement a long-term radiation medicine infrastructure and plan to improve capacity.
[Mh] Termos MeSH primário: Agências Internacionais/organização & administração
Neoplasias/diagnóstico por imagem
Neoplasias/radioterapia
Energia Nuclear
Radioterapia (Especialidade)/organização & administração
[Mh] Termos MeSH secundário: Países em Desenvolvimento
Feminino
Planejamento em Saúde/organização & administração
Seres Humanos
Masculino
Determinação de Necessidades de Cuidados de Saúde
Medicina Nuclear
Peru
Medição de Risco
Papel (Figurativo)
[Pt] Tipo de publicação:EVALUATION STUDIES; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171012
[Lr] Data última revisão:
171012
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171004
[St] Status:MEDLINE


  4 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28961588
[Au] Autor:de With G
[Ad] Endereço:*Nuclear Research and Consultancy Group (NRG), Utrechtseweg 310, NL-6800 ES Arnhem, The Netherlands.
[Ti] Título:Development of an Assessment Method for Building Materials Under Euratom Scope.
[So] Source:Health Phys;113(5):392-403, 2017 Nov.
[Is] ISSN:1538-5159
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:In 2013, the European Commission published its basic safety standards for protection against the dangers arising from exposure to ionizing radiation (Council Directive 2013/59/Euratom)-also known as EU-BSS. As a result, the use of raw materials with potentially elevated activity concentrations such as fly ash, phosphogypsum, and slags will now fall under EU-BSS scope when applied in building materials. In light of this new policy, a variety of tools are available to assess compliance with the 1-mSv y reference level for building materials. At the heart of these tools is a gamma-spectrometric determination of the naturally occurring radionuclides Ra, Th, and K in the material of concern. As a large number of construction products contain a certain amount of the raw material that falls under the scope of the EU regulation, this policy will lead to substantial measurement of building materials that pose little radiation risk. For this reason, a method is developed to enable assessment against the 1-mSv value not on the basis of gamma-spectrometric analysis but rather based on the product's material composition. The proposed method prescribes a maximum permitted content of raw materials with potentially elevated activity concentrations in terms of a weight percentage of the end product, where the raw materials of concern are defined as those listed in Annex XIII of the EU-BSS. The permitted content is a function of the product's surface density. Therefore, a product with a low surface density of up to 25 kg m can consist of nearly 100% raw materials with potentially elevated activity concentrations, and this percentage drops to around 15% for products with a surface density of around 500 kg m. Building materials that comply with these requirements on product composition are exempt from testing, while products that do not comply must perform regular gamma-spectrometric analysis. A full validation and testing of the method is provided. In addition, the paper discusses issues relevant for regulatory implementation.
[Mh] Termos MeSH primário: Materiais de Construção
Agências Internacionais
Monitoramento de Radiação/métodos
[Mh] Termos MeSH secundário: Indústrias
Dose de Radiação
Monitoramento de Radiação/normas
Padrões de Referência
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171010
[Lr] Data última revisão:
171010
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170930
[St] Status:MEDLINE
[do] DOI:10.1097/HP.0000000000000746


  5 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28846587
[Au] Autor:Repacholi MH
[Ad] Endereço:*Department of Information Engineering, Electronics and Telecommunications (DIET), University of Rome 'La Sapienza,' Rome, Italy.
[Ti] Título:A History of the International Commission on Non-Ionizing Radiation Protection.
[So] Source:Health Phys;113(4):282-300, 2017 Oct.
[Is] ISSN:1538-5159
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Concern about health risks from exposure to non-ionizing radiation (NIR) commenced in the 1950s after tracking radars were first introduced during the Second World War. Soon after, research on possible biological effects of microwave radiation in the former Soviet Union and the U.S. led to public and worker exposure limits being much lower in Eastern European than in Western countries, mainly because of different protection philosophies. As public concern increased, national authorities began introducing legislation to limit NIR exposures from domestic microwave ovens and workplace devices such as visual display units. The International Radiation Protection Association (IRPA) was formed in 1966 to represent national radiation protection societies. To address NIR protection issues, IRPA established a Working Group in 1974, then a Study Group in 1975, and finally the International NIR Committee (INIRC) in 1977. INIRC's publications quickly became accepted worldwide, and it was logical that it should become an independent commission. IRPA finally established the International Commission on Non-Ionizing Radiation Protection (ICNIRP), chartering its remit in 1992, and defining NIR as electromagnetic radiation (ultraviolet, visible, infrared), electromagnetic waves and fields, and infra- and ultrasound. ICNIRP's guidelines have been incorporated into legislation or adopted as standards in many countries. While ICNIRP has been subjected to criticism and close scrutiny by the public, media, and activists, it has continued to issue well-received, independent, science-based protection advice. This paper summarizes events leading to the formation of ICNIRP, its key activities up to 2017, ICNIRP's 25th anniversary year, and its future challenges.
[Mh] Termos MeSH primário: Agências Internacionais/história
Proteção Radiológica/história
Radiação não Ionizante
[Mh] Termos MeSH secundário: Comitês Consultivos/história
História do Século XX
História do Século XXI
Seres Humanos
Cooperação Internacional/história
Radiação não Ionizante/efeitos adversos
Organização Mundial da Saúde/história
[Pt] Tipo de publicação:HISTORICAL ARTICLE; JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170915
[Lr] Data última revisão:
170915
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170829
[St] Status:MEDLINE
[do] DOI:10.1097/HP.0000000000000699


  6 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28696044
[Au] Autor:Rao AD; Chen Q; Ermoian RP; Alcorn SR; Figueiredo MLS; Chen MJ; Dieckmann K; MacDonald SM; Ladra MM; Kobyzeva D; Nechesnyuk AV; Nilsson K; Ford EC; Winey BA; Villar RC; Terezakis SA
[Ad] Endereço:Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD.
[Ti] Título:Practice patterns of palliative radiation therapy in pediatric oncology patients in an international pediatric research consortium.
[So] Source:Pediatr Blood Cancer;64(11), 2017 Nov.
[Is] ISSN:1545-5017
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND/OBJECTIVES: The practice of palliative radiation therapy (RT) is based on extrapolation from adult literature. We evaluated patterns of pediatric palliative RT to describe regimens used to identify opportunity for future pediatric-specific clinical trials. DESIGN/METHODS: Six international institutions with pediatric expertise completed a 122-item survey evaluating patterns of palliative RT for patients ≤21 years old from 2010 to 2015. Two institutions use proton RT. Palliative RT was defined as treatment with the goal of symptom control or prevention of immediate life-threatening progression. RESULTS: Of 3,225 pediatric patients, 365 (11%) were treated with palliative intent to a total of 427 disease sites. Anesthesia was required in 10% of patients. Treatment was delivered to metastatic disease in 54% of patients. Histologies included neuroblastoma (30%), osteosarcoma (18%), leukemia/lymphoma (12%), rhabdomyosarcoma (12%), medulloblastoma/ependymoma (12%), Ewing sarcoma (8%), and other (8%). Indications included pain (43%), intracranial symptoms (23%), respiratory compromise (14%), cord compression (8%), and abdominal distention (6%). Sites included nonspine bone (35%), brain (16% primary tumors, 6% metastases), abdomen/pelvis (15%), spine (12%), head/neck (9%), and lung/mediastinum (5%). Re-irradiation comprised 16% of cases. Techniques employed three-dimensional conformal RT (41%), intensity-modulated RT (23%), conventional RT (26%), stereotactic body RT (6%), protons (1%), electrons (1%), and other (2%). The most common physician-reported barrier to consideration of palliative RT was the concern about treatment toxicity (83%). CONCLUSION: There is significant diversity of practice in pediatric palliative RT. Combined with ongoing research characterizing treatment response and toxicity, these data will inform the design of forthcoming clinical trials to establish effective regimens and minimize treatment toxicity for this patient population.
[Mh] Termos MeSH primário: Neoplasias/radioterapia
Cuidados Paliativos
Padrões de Prática Médica/normas
Planejamento da Radioterapia Assistida por Computador/métodos
Radioterapia de Intensidade Modulada/métodos
[Mh] Termos MeSH secundário: Adolescente
Adulto
Criança
Pré-Escolar
Feminino
Seguimentos
Seres Humanos
Lactente
Recém-Nascido
Agências Internacionais
Masculino
Estadiamento de Neoplasias
Neoplasias/patologia
Prognóstico
Dosagem Radioterapêutica
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171025
[Lr] Data última revisão:
171025
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170712
[St] Status:MEDLINE
[do] DOI:10.1002/pbc.26589


  7 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28666622
[Au] Autor:Zhang Y; Spedding M; Wainwright C; Schini-Kerth V; Bermano G
[Ad] Endereço:Beijing Institute of Pharmacology & Toxicology, Beijing, China.
[Ti] Título:Joint ICMAN and IUPHAR natural products section meeting. Aberdeen UK 27-29th September 2017.
[So] Source:Biochem Pharmacol;139:1-2, 2017 Sep 01.
[Is] ISSN:1873-2968
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:This special issue of Biochemical Pharmacology contains proceedings of a joint conference sponsored by the Natural Products Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the International Conference on the Mechanism of Action of Nutraceuticals (ICMAN), an organization dedicated to defining actions and clinical benefits of pharmaceuticals and nutraceuticals. Entitled "From Nutraceuticals to Pharmaceuticals: Common Challenges and Approaches", the conference was held in Aberdeen UK in September 2017. The aim of this gathering was to identify the challenges that must be overcome to identify and characterize novel therapeutics from natural products. Contained in this issue are reviews prepared by conference participants as well as abstracts describing oral and poster presentations.
[Mh] Termos MeSH primário: Produtos Biológicos/uso terapêutico
Pesquisa Biomédica/métodos
Suplementos Nutricionais
[Mh] Termos MeSH secundário: Animais
Produtos Biológicos/efeitos adversos
Pesquisa Biomédica/tendências
Suplementos Nutricionais/efeitos adversos
Descoberta de Drogas/métodos
Descoberta de Drogas/tendências
Seres Humanos
Agências Internacionais
Medicina Tradicional/métodos
Medicina Tradicional/tendências
Sociedades Científicas
[Pt] Tipo de publicação:CONGRESSES; EDITORIAL; INTRODUCTORY JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Biological Products)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170818
[Lr] Data última revisão:
170818
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170702
[St] Status:MEDLINE


  8 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28429300
[Au] Autor:Suárez-Torres J; Suárez-López JR; López-Paredes D; Morocho H; Cachiguango-Cachiguango LE; Dellai W
[Ad] Endereço:Fundacion Cimas del Ecuador, Ave. Los Olivos E14-226, Quito, Ecuador. jsuarez@cimas.edu.ec.
[Ti] Título:Agroecology and Health: Lessons from Indigenous Populations.
[So] Source:Curr Environ Health Rep;4(2):244-251, 2017 Jun.
[Is] ISSN:2196-5412
[Cp] País de publicação:Switzerland
[La] Idioma:eng
[Ab] Resumo:PURPOSE OF REVIEW: The article aims to systematize and disseminate the main contributions of indigenous ancestral wisdom in the agroecological production of food, especially in Latin America. For this purpose, it is necessary to ask whether such knowledge can be accepted by academia research groups and international forums as a valid alternative that could contribute to overcome the world's nutritional problems. RECENT FINDINGS: Although no new findings are being made, the validity of ancestral knowledge and agroecology is recognized by scientific research, and by international forums organized by agencies of the United Nations. These recommend that governments should implement them in their policies of development, and in the allocation of funds to support these initiatives. Agroecology and ancestral knowledge are being adopted by a growing number of organizations, indigenous peoples and social groups in various parts of the world, as development alternatives that respond to local needs and worldviews. Its productive potential is progressively being recognized at an international level as a model that contributes to improve the condition of people regarding nutritional food.
[Mh] Termos MeSH primário: Ecologia
Nível de Saúde
Agricultura Orgânica/métodos
Grupos Populacionais
[Mh] Termos MeSH secundário: Países em Desenvolvimento
Seres Humanos
Agências Internacionais
América Latina
Política Pública
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171114
[Lr] Data última revisão:
171114
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170422
[St] Status:MEDLINE
[do] DOI:10.1007/s40572-017-0146-z


  9 / 7580 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28428214
[Au] Autor:Berger D
[Ad] Endereço:Kalang, NSW, Australia.
[Ti] Título:Time for an overhaul at the World Medical Association.
[So] Source:BMJ;357:j1955, 2017 04 20.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Pessoal Administrativo
Agências Internacionais/organização & administração
Má Conduta Profissional
Sociedades Médicas/organização & administração
[Mh] Termos MeSH secundário: Crime
Ética Institucional
Índia
Agências Internacionais/ética
Sociedades Médicas/ética
[Pt] Tipo de publicação:EDITORIAL
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170422
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.j1955


  10 / 7580 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28383760
[Au] Autor:Vujanic GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
[Ad] Endereço:Department of Cellular Pathology, University Hospital of Wales/Cardiff University School of Medicine, Cardiff, United Kingdom.
[Ti] Título:Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
[So] Source:Pediatr Blood Cancer;64(11), 2017 Nov.
[Is] ISSN:1545-5017
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Nephrogenic rests (NRs) are abnormally persistent foci of embryonal cells, thought to be the precursor lesion of Wilms tumors (WTs). To date, their presence has not been systematically examined in WTs treated with preoperative chemotherapy. METHODS: A systematic analysis of the data on NRs in WTs treated with preoperative chemotherapy obtained from the UK cohort of the International Society of Pediatric Oncology (SIOP) WT 2001 Trial. The study was based on central pathology review of full sets of slides from pathological specimens, with a median of 28 slides reviewed per case. RESULTS: NRs were identified in 40% of unilateral WTs, including 25% perilobar nephrogenic rest (PLNR), 9% intralobar nephrogenic rest (ILNR), 5% both PLNR and ILNR, and 1% nephroblastomatosis, and in 93% of cases with bilateral lesions. ILNRs were associated with stromal histology and a younger age at diagnosis and found frequently in patients with congenital anomalies associated with WT1 mutation. PLNRs were found frequently in patients with overgrowth syndromes. CONCLUSIONS: The prevalence of NRs in WTs after preoperative chemotherapy observed in SIOP UK WT 2001 Trial is similar to the previously published data on NRs not treated with preoperative chemotherapy. Their epidemiology supports at least two pathways to Wilms tumorigenesis.
[Mh] Termos MeSH primário: Antineoplásicos/uso terapêutico
Neoplasias Renais/patologia
Tumor de Wilms/patologia
[Mh] Termos MeSH secundário: Seguimentos
Seres Humanos
Agências Internacionais
Neoplasias Renais/tratamento farmacológico
Neoplasias Renais/epidemiologia
Estadiamento de Neoplasias
Cuidados Pré-Operatórios
Prevalência
Prognóstico
Reino Unido/epidemiologia
Tumor de Wilms/tratamento farmacológico
Tumor de Wilms/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY
[Nm] Nome de substância:
0 (Antineoplastic Agents)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171025
[Lr] Data última revisão:
171025
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170407
[St] Status:MEDLINE
[do] DOI:10.1002/pbc.26547



página 1 de 758 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde